Skip to main navigation Skip to search Skip to main content

Prevention of bleomycin-induced pulmonary fibrosis in the hamster by Cis-4-hydroxy-L-proline

  • D. J. Riley
  • , J. S. Kerr
  • , R. A. Berg
  • , B. D. Ianni
  • , G. G. Pietra
  • , N. H. Edelman
  • , D. J. Prockop

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

We investigated the effect of the proline analogue cis-hydroxyproline on pulmonary fibrosis produced by intratracheal administration of bleomycin in hamsters. Two groups of animals received a single dose of bleomycin; one of these groups was also injected with cis-hydroxyproline twice daily for 30 days. Control animals received intratracheal saline. Lungs were examined on day 30. In the bleomycin group, the collagen content of lungs was 131% of the control value (p < 0.05). Administration of cis-hydroxyproline significantly decreased collagen accumulation to 114% of the control value (p < 0.05). Pressure-volume curves were significantly shifted downward and to the right of control in the bleomycin group; this shift was partially prevented by cis-hydroxyproline. Morphometric studies showed that alveolar walls comprised 15% of the lung parenchyma in the control group and 19% in the bleomycin group (p < 0.05). Administration of cis-hydroxyproline significantly decreased alveolar walls to 16% of the lung parenchyma (p < 0.05). We conclude that cis-hydroxyproline partially prevents the chemical, structural, and functional changes of bleomycin-induced pulmonary fibrosis in the hamster.

Original languageEnglish
Pages (from-to)388-393
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume123
Issue number4
StatePublished - 1981

Fingerprint

Dive into the research topics of 'Prevention of bleomycin-induced pulmonary fibrosis in the hamster by Cis-4-hydroxy-L-proline'. Together they form a unique fingerprint.

Cite this